We have investigated the interaction of ohgonucleotides and their alkylating derivatives with mammalian cells. In experiments with L929 mouse fibroblast and Krebs 2 ascites carcinoma cells, it was found that cellular uptake of oligodeoxynucleotide derivatives is achieved by an endocytosis mechanism. Uptake is considerably more efficient at low oligomer concentration (<1 jAM), because at this concentration a significant percentage of the total oligomer pool is absorbed on the cell surface and internalized by a more efficient absorptive endocytosis process. Two modified proteins were detected in mouse fibroblasts that were treated with the alkylating oligonucleotide derivatives. The binding of the oligomers to the proteins is inhibited by other oligodeoxynucleotides, single-and double-stranded DNA, and RNA. The polyanions heparin and chondroitin sulfates A and B do not inhibit binding. These observations suggest the involvement of specific receptor proteins in binding of oligomers to mammalian cells.
Antisense oligodeoxynucleotides and their derivatives have been shown to be specific inhibitors ofgene expression. They have been considered as a potential new generation of drugs, capable perhaps of inhibiting various pathogens and of regulating specific gene expression by inhibiting the translation of mRNA molecules in a highly specific manner (1) (2) (3) (4) . However, a prevailing view is that cells are not very permeable to oligonucleotides. Considerable efforts have been made to design nonionic membrane-permeable analogs (5) and to develop special delivery techniques (6, 7) . Nevertheless, it has also been shown that normal unsubstituted oligonucleotides can cause hybridization arrest of specific mRNAs and viruses in cell culture (8) (9) (10) (11) . These observations provide evidence that oligodeoxynuicleotides do indeed enter cells. Recently, the ability of oligonucleotides to enter mammalian cells has been proved experimentally (9, (11) (12) (13) (14) .
The present investigation studied the interaction of oligodeoxynucleotide derivatives with mammalian cells. We examined the efficiency of oligomer binding and the time course of oligomer internalization under various conditions. We also investigated the stability of the internalized oligomers. Experiments involving the reactive 4-[N-(2-chloroethyl)-N-methyl]aminobenzyl phosphamide derivative of oligodeoxynucleotides [general formula ClRCH2NHpTTFr..., where R = -CH2CH2N(CH3)C6Hr--- (1) ]t were also undertaken: reagents of this type have recently been used by us as inhibitors of the influenza and tick-borne encephalitis viruses (4, 15) . In the present study, these reagents were used to chemically modify the putative cellular receptors binding oligonucleotides. Laemmli (20) .
MATERIALS AND METHODS
RESULTS AND DISCUSSION Fig. 1 shows the time course of the interaction of the 32P-labeled oligonucleotide (pT)9 and its alkylating derivative with mouse fibroblast cells. The aromatic groups of the derivative appeared to slightly enhance the binding. The kinetics of binding of each molecular species is similar and the maximal binding is observed within 2 hr after the addition of the oligomers. Similar to what has been recognized with a process involving endocytosis (21) , the binding of oligodeoxynucleotides by cells proceeds more slowly at lower temperatures ( Fig. 2) . Known inhibitors of endocytosis-e.g., sodium azide' (5 mM), deoxyglucose (20 ,uM) , and cytochalasin B (50 iug/ml)-inhibit the uptake of ClRCH2NH(pT)9 by the mouse fibroblasts by a factor of 2.5-3. The' efficiency of the oligomer internalization depends on the conditions of the cell growth. Thus, an increase in the cell monolayer density from 8 x 104 cells per cm2 to 5 x 105 cells per cm2 resulted in a decrease ofthe maximal binding ofthe oligomer (per cell) by a factor of 3.
It should be noted that no cytotoxic effects were observed when cells were incubated for 4 hr in the presence of 100 ,tM alkylating derivatives, as judged by the intensity of the protein synthesis assay.
The kinetics of oligomer binding, which demonstrated a plateauing effect within a 2-hr incubation time, is similar in a broad concentration range (0.01-100 uM). Fig.' 3 shows the dependence of the limit binding level on the oligodeoxynucleotide concentration in the medium. At high oligomer concentration, the efficiency of uptake is similar to that of polyvinylpyrrolidone, a substance known to be taken up by pinocytosis (22) . Under the conditions used in our experiments, the concentration of the oligodeoxynucleotides in cells is -1/10th that in the medium in accordance with the earlier findings (9) . At Fig. 1 . endocytosis). At low oligonucleotide concentrations, the contribution of this process predominates.
Since the plateau level'of the oligomer binding curves depends on the oligomer concentration, the data presented in Fig. 3 suggest that at 2 hr. of incubation the endocytosis process is in equilibrium with oligomer exocytosis.-The data shown in Fig. 4 demonstrate that the 3plabel is liberated from the cells and may be found in the medium. TUp to 70% of the cell-bound label may be liberated from the cells; the rest ofthe material appeared to be bound irreversibly. Similar binding-liberation curves were obtained for [lCsucrose (Fig. 4) , which is known to be taken up by mouse fibroblasts by endocytosis (23) . Krebs We studied the stability of the oligomers internalized by the cells by using gel electrophoresis analysis. ments with other cells (9, 11, 13) . Incubation of the labeled oligomer-treated cells in the fresh medium results in a partial release of the radioactive material from the cells. Comparison of the electrophoretic patterns in lanes 1-3 with lanes 4-7 (Fig. 5) shows that products of the oligonucleotide derivative degradation are more" easily liberated from the cells as compared to the parent compound. This may suggest that the degradation products are in some cellular compartments more easily communicating with the extracellular medium. One may speculate, therefore, that there are two pathways involved in the cellular uptake of oligonucleotides and that one of the pathways may provide irreversible internalization in an environment with low nuclease activity. Results of the similar experiments performed with the reactive derivatives of oligonucleotides pTTCCTTCCCGTCTTCC and (pT) 16 were very similar to those described above except for radiolabeled products; apparently modified biopolymers appeared at the starts of the electrophoretic runs. It was noticed that the degradation of ClRCH2NHpTTCCTTCCCGTCTTCC proceeded somewhat faster as compared to CIRCH2NH-(pT) 16 . It was found that in cells incubated with the 32p_ labeled oligonucleotide derivatives, =20% of the radioactive material taken up was bound in the cell nuclei and -50% of the material was associated with the fractions containing mitochondria, lysosomes, and other vesicular structures. The association of a substantial amount of the material with vesicular structures is consistent with an endocytosis uptake mechanism.
These results led to experiments designed to determine whether a specific cell-surface protein was involved in oligodeoxynucleotide binding. We investigated the chemical modification of mouse fibroblast proteins with the alkylating oligonucleotide derivative 32P-labeled ClRCH2NH(pT) 16 . This derivative contains an aromatic 2-chloroethylamino group capable of modifying nucleophilic centers in both nucleic acids and proteins (1). It was found that 30 min incubation of the cells with the reagent (0.15 tkM) resulted in the appearance of two labeled proteins of 79'and 90 kDa (Fig.  6a) . Upon prolonged incubation of the cells with the reagent, the modification pattern remained essentially the same, although some additional bands corresponding apparently to modified intracellular proteins appeared (Fig. 6c) . As shown by data in Fig. 6 , the modification reaction is a specific process. Modification of the proteins is inhibited by other oligodeoxynucleotides and nucleic acids (tRNA, singlestranded DNA, double-stranded DNA) added in excess over the oligodeoxynucleotide derivative (Fig. 6a ). Heparin and chondroitin sulfates A and B do not affect the alkylation reaction even when they are present in 10-fold or even 25-fold (heparin) molar excesses. However, increases in the reagent concentration increased the amount of protein modification (Fig. 6b ). At concentrations above 2.5 ,uM, a nonspecific reaction with cellular proteins may be observed. Fig. 7 shows the concentration dependence of the specific label incorporation in the two proteins as determined by counting the protein bands cut off the gel shown in Fig. 6b . The curve plateaus at reagent concentration above 1 ,uM. This is similar to the concentration-dependence curve for the oligodeoxynucleotide binding process (Fig. 3) vations are consistent with those of Loke et al. (25) , who have investigated the interaction of fluorescent oligonucleotide derivatives with mammalian cells. Their results also suggest that there is the endocytic mechanism of oligodeoxynucleotide uptake. They succeeded in isolating an 80-kDa protein, which apparently binds oligodeoxynucleotides, nucleotides, tRNA, and plasmids.
Although at present the biological role of the oligodeoxynucleotide binding protein or proteins remains obscure, it is possible that they may be utilized to construct more efficient approaches for delivery of antisense oligodeoxynucleotides into cells. 
